An observational study in Stimulant Abuse and Criminal Behavior, sponsored by The Mind Research Network. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by The Mind Research Network · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Criminal Behavior with a site in United States — 4 open to participants now, 7 under way, none of them phase 3. Criminal Behavior · United States.
Among the 22 studies in Criminal Behavior with a site in United States, this one is one of 2 that started in 2022, is the only observational one, and was the 19th registered.
29 studies on the registry are indexed under Criminal Behavior; 8 are open to participants now.
Browse Criminal Behavior studies →4 of the 22 studies in Criminal Behavior with a site in United States are open now. Recruiting first, the newest first:
University of Michigan · Sites in United States
Ages 18+
Iowa State University · Sites in United States
Ages 18+ · Men only
Texas Christian University · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 6 Criminal Behavior studies recruiting now, 2 set no upper age limit and 4 stop at 75 or younger; 3 take children under 18; 1 takes healthy volunteers.
This study: 18 Years to 70 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 2 started in 2022.
Median enrollment 200 across the 21 interventional studies, 334 across the 1 observational. Of the 12 that completed or were terminated, 2 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 22 have an industry lead sponsor. The 10 most frequent:
The Mind Research Network is the lead sponsor of 18 studies on the registry; 5 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 4 (67%) have results posted.
The Mind Research Network has 2 studies filed under Criminal Behavior — fewer than ten, so there is no comparison to draw.
3 of the studies in Criminal Behavior with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05109689Iowa State UniversityA Randomized Controlled Trial of ACT-P Versus T4C for Community Reentry | 2026-12 |
| NCT05845333The Mind Research NetworkNeurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women | 2027-05-31 |
| NCT05974553VA Office of Research and DevelopmentDialectical Behavior Therapy for Justice-Involved Veterans | 2027-06-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 22 studies in Criminal Behavior with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Substance use disorders and psychopathy are serious and costly mental health issues. Psychopathy is known to be associated with aberrant moral decision making and there is considerable interest in determining whether substance use disorders lead to impairments in these same cognitive processes. Recent large-scale research initiatives in forensic settings have begun to identify substance abuse and psychopathy-related disruption in the neural mechanisms involved in moral decision-making processes, and associations between these neural networks and future relapse and antisocial behavior. Here the investigators extend prior work (with incarcerated men) to examine these issues among incarcerated women in order to better understand sex differences. This project addresses the overall lack of neurocognitive research in criminal offenders with substance use disorders, thereby focusing on a major public health issue in an underserved and understudied population.
There continues to be great interest and public health relevance with regard to understanding the neurobiological systems that underlie the comorbidity of substance use disorders and other psychiatric conditions. In a previous award, efforts were focused upon characterizing the neural circuitry underlying moral decision making in incarcerated men with varying levels of two frequently co-occurring conditions: stimulant abuse and psychopathy. Here this work will be extended to incarcerated women, to examine longitudinal outcomes and apply state-of-the-art network analyses for predictive models. Prior studies have demonstrated sex differences in the degree and expression of psychopathic traits, patterns of stimulant abuse, and moral decision-making. However, the neural circuitry that underlies these sex differences is not well understood. Substantial sex differences in regional gray matter volume and density in extant samples have also been identified. Collectively, sex differences in pathophysiology could have significant implications for treatment strategies and differential biomarkers of treatment prediction and outcome in men and women. The investigators will implement the research strategy with a large incarcerated population by deploying a unique mobile MRI scanner to the regional women's prison. Participants will be stratified by level of lifetime stimulant (cocaine, amphetamine) use severity and psychopathic traits (high, medium, low) and will undergo anatomical and functional MRI scanning while completing multi-modal (i.e., linguistic and picture) decision-making tasks. Results will be compared to those obtained in a prior award (incarcerated men, n>300). Functional network and dynamic network connectivity will also be examined in women using a new multiband echo planar imaging (EPI) pulse sequence, and longitudinal outcomes after release to the community will be collected to test behavioral and neuropredictive models of relapse and future antisocial behavior. This work is expected to generate a large, robust dataset that characterizes the overlapping and unique aspects of neural circuitry underlying stimulant use and psychopathy in females and males. The proposed research is in line with recent priorities emphasized by the National Institute on Drug Abuse (NIDA) for projects aimed at examining male-female differences, and effects specific to females, to improve understanding of the nature and etiology of drug abuse.
Incarcerated and non-incarcerated adult women
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
(Healthy controls only):
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Decision task
Other: Decision task
Other: Decision task
Other: Decision task
Other: Decision task
Other: Decision task
Other: Decision task
Participants will complete a simple and/or moral decision making functional MRI task.
Gray matter volume during MRI scan & stimulant use
Gray matter volume (using relevant MRI analysis platforms - Statistical Parametric Mapping/SPM) correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
Time frame: During MRI procedure
White matter integrity during MRI scan & stimulant use
White matter integrity (using relevant MRI analysis platforms - Functional Magnetic Resonance Imaging of the Brain software library (FSL)) correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
Time frame: During MRI procedure
Functional brain response during MRI scan & stimulant use during simple linguistic decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Simple Linguistic Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
Time frame: During MRI procedure
Functional brain response during MRI scan & stimulant use during simple picture decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Simple Picture Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
Time frame: During MRI procedure
Functional brain response during MRI scan & stimulant use during moral linguistic decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Moral Linguistic Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
Time frame: During MRI procedure
Functional brain response during MRI scan & stimulant use during moral picture decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Moral Picture Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
Time frame: During MRI procedure
Functional connectivity during MRI scan & stimulant use during simple linguistic decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Simple Linguistic Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
Time frame: During MRI procedure
Functional connectivity during MRI scan & stimulant use during simple picture decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Simple Linguistic Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
Time frame: During MRI procedure
Functional connectivity during MRI scan & stimulant use during moral linguistic decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Moral Linguistic Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
Time frame: During MRI procedure
Functional connectivity during MRI scan & stimulant use during moral picture decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Moral Picture Decision Task correlation with stimulant use (assessed using a modified version of the Addiction Severity Index)
Time frame: During MRI procedure
Gray matter volume during MRI scan & psychopathic traits
Gray matter volume (using relevant MRI analysis platforms - Statistical Parametric Mapping/SPM) correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
Time frame: During MRI procedure
White matter integrity during MRI scan & psychopathic traits
White matter integrity (using relevant MRI analysis platforms - Functional Magnetic Resonance Imaging of the Brain software library (FSL)) correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
Time frame: During MRI procedure
Functional brain response during MRI scan & psychopathic traits during simple linguistic decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Simple Linguistic Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
Time frame: During MRI procedure
Functional brain response during MRI scan & psychopathic traits during simple picture decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Simple Picture Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
Time frame: During MRI procedure
Functional brain response during MRI scan & psychopathic traits during moral linguistic decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Moral Linguistic Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
Time frame: During MRI procedure
Functional brain response during MRI scan & psychopathic traits during moral picture decision task
Functional brain responses (Blood Oxygen Level Dependent/BOLD) (using relevant MRI analysis platforms - SPM, Group Independent Components Analysis Functional Toolbox/GIFT) during Moral Picture Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
Time frame: During MRI procedure
Functional connectivity during MRI scan & psychopathic traits during simple linguistic decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Simple Linguistic Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
Time frame: During MRI procedure
Functional connectivity during MRI scan & psychopathic traits during simple picture decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT)) during Simple Picture Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
Time frame: During MRI procedure
Functional connectivity during MRI scan & psychopathic traits during moral linguistic decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Moral Linguistic Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
Time frame: During MRI procedure
Functional connectivity during MRI scan & psychopathic traits during moral picture decision task
Functional connectivity (using relevant analysis MRI platforms - GIFT) during Moral Picture Decision Task correlation with psychopathic traits (assessed using the Psychopathy Checklist-Revised)
Time frame: During MRI procedure
Relapse to/change in stimulant use post-release
Return to stimulant use (assessed using timeline follow back calendar (TLFB)) post-release from incarceration
Time frame: Every 3 months post release for duration of grant (5 years)
Return to/change in antisocial behavior post-release
Return to antisocial behavior (assessed via self report and/or official records) post-release from incarceration
Time frame: Every 3 months post release for duration of grant (5 years)
Started Aug 2022 (actual). Primary completion is estimated for May 2027, 57 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Mind Research Network